chlordiazepoxide has been researched along with pindolol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Coop, CF; McNaughton, N; Scott, DJ | 1 |
| Curzon, G; Haleem, DJ; Kennett, GA; Whitton, PS | 1 |
| Oswald, WD | 1 |
| de Castro, B; Domingues, V; Gameiro, P; Lima, JL; Oliveira, A; Reis, S | 1 |
| Chen, CF; Hung, WY; Liao, JF | 1 |
1 review(s) available for chlordiazepoxide and pindolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for chlordiazepoxide and pindolol
| Article | Year |
|---|---|
[Anxiolysis and reduction of subjectively scaled "strain" in cognitive stress by means of pindolol].
Topics: Adult; Anxiety; Chlordiazepoxide; Drug Evaluation; Humans; Neurotic Disorders; Pindolol; Placebos; Stress, Psychological; Surveys and Questionnaires | 1980 |
11 other study(ies) available for chlordiazepoxide and pindolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pindolol antagonizes the effects on hippocampal rhythmical slow activity of clonidine, baclofen and 8-OH-DPAT, but not chlordiazepoxide and sodium amylobarbitone.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Amobarbital; Animals; Baclofen; Chlordiazepoxide; Clonidine; Electric Stimulation; Electrodes; Electroencephalography; Flumazenil; Hippocampus; Male; Pindolol; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes | 1992 |
8-OH-DPAT increases corticosterone but not other 5-HT1A receptor-dependent responses more in females.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Chloral Hydrate; Chlordiazepoxide; Corticosterone; Eating; Female; Hypothalamus, Middle; Injections; Male; Naphthalenes; Pindolol; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sex Factors; Stress, Psychological; Temperature; Tetrahydronaphthalenes | 1989 |
Acid-base properties and solubility of pindolol, diazepam and chlordiazepoxide in SDS micelles.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Chlordiazepoxide; Diazepam; Hydrogen-Ion Concentration; Kinetics; Micelles; Pindolol; Sodium Dodecyl Sulfate; Solubility; Water | 1999 |
Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Chlordiazepoxide; Conflict, Psychological; Dose-Response Relationship, Drug; Drinking; Drinking Behavior; Flavanones; Flavonoids; Flumazenil; GABA Modulators; Male; Mice; Mice, Inbred ICR; Pindolol; Psychological Tests; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |